Levothyroxine Sodium Tablets Recalled Due to Subpotent Drug Concerns
Major Pharmaceuticals is voluntarily recalling certain lots of Levothyroxine Sodium Tablets (75 mcg) because the medication may be subpotent.
What this means for you
Real risk of harm even if no illness or injury has been reported yet. Stop using the product and follow the agency's guidance.
Our severity reasoning: The recall is for a subpotent drug, which poses a risk of harm because the medication may not effectively treat the patient's condition.
Plain-English summary
Major Pharmaceuticals has initiated a voluntary recall of Levothyroxine Sodium Tablets, USP, 75 mcg (0.075 mg). The affected products are packaged in 10-tablet unit dose blisters per carton and are distributed nationwide in the USA.
The recall was initiated because the medication may be subpotent, meaning it may not contain the intended amount of the active ingredient. This can lead to ineffective treatment of the condition the medication is intended to manage.
Consumers should check their medication's lot numbers and expiration dates. If you have the affected product, contact your pharmacist or healthcare provider for guidance on replacement medication.
The recalled product
- Product
- LEVOTHYROXINE SODIUM (LEVOTHYROXINE SODIUM)
- Brand
- LEVOTHYROXINE SODIUM
- Manufacturer
- Major Pharmaceuticals
- Category
- Drug — Prescription Medication
- Hazard
- subpotent-drug
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (8)
- Bag lot #: N02172A
- N02172B
- Exp. Date 07/2026
- N02288A
- N02288B
- Exp. Date 12/2026
- Blister lot #: N02172
- N02288
UPCs (1)
- 0055154356305
Distribution
Distributed nationwide across the United States.
Related recalls
Same brand · LEVOTHYROXINE SODIUM
- SevereLevothyroxine Sodium Tablets Recalled for Subpotency
FDA (Drugs) · 2026-07-29
- HighLevothyroxine Sodium Tablets Recalled for Subpotency by Major Pharmaceuticals
FDA (Drugs) · 2026-07-29
- SevereLevothyroxine Sodium Tablets Recalled for Subpotency
FDA (Drugs) · 2026-07-29
- HighLEVOTHYROXINE SODIUM Tablets Recalled Due to Subpotent Drug Content
FDA (Drugs) · 2026-07-29
- SevereMajor Pharmaceuticals Recalls Levothyroxine Sodium Tablets Over Subpotency
FDA (Drugs) · 2026-07-29
Same category
- HighNaropin Injection Recall Over Particulate Matter Contamination
FDA (Drugs) · 2026-07-29
- HighLidocaine Injection Recall Due to Hair Contamination
FDA (Drugs) · 2026-07-29
- ModerateFDA Recalls Xylocaine Injections Due to Hair Contamination
FDA (Drugs) · 2026-07-29
- HighRohto Cooling Eye Drops Max Strength Recalled Due to Sterility Concerns
FDA (Drugs) · 2026-07-29
- HighXylocaine Injection Recall Due to Hair Contamination
FDA (Drugs) · 2026-07-29